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Background: Curcumin (CUR), an active polyphenol derived from the spice turmeric, has been traditionally used for
centuries in ancient Indian medicine to treat a number of diseases. The physiological effects of CUR have been
shown to be diverse; however, the target molecules and pathways that CUR affects have yet to be fully described.
Results: Here, we demonstrate for the first time that the budding yeast mitogen-activated protein kinase (MAPK) Hog1
is essential for the response to CUR. Moreover, CUR-induced Hog1 phosphorylation was rescued by supplementation
of iron to the growth medium. Hog1 was rapidly phosphorylated upon CUR treatment, but unlike the response to
hyperosmotic shock (0.8 M NaCl), it remains activated for an extended period of time. A detailed analysis of HOG
pathway mutants revealed that Pbs2p, Ptc2p, and Ssk2p are required for optimal CUR-induced Hog1 phosphorylation.
We also observed a Hog1 dependent transcriptional response to CUR treatment that involved the up-regulation of
glycerol-3-phosphate dehydrogenase 1 (GPD1), a factor that is essential for the hyperosmotic stress response.
Conclusions: Our present finding revealed the role of Hog1 MAPK in regulation of CUR-induced transcriptional
response. We anticipate that our finding will enhance the understanding on the molecular mode of action of
CUR on S. cerevisiae.
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1 (GPD1), Mitogen-activated protein kinasesBackground
Yeast cells have evolved sophisticated mechanisms to
withstand a variety of stresses including limited availability
of nutrients, fluctuations in temperature, changes in
osmolarity, and the presence of harmful agents such as
radiation or toxic chemicals. A myriad of strategies have
evolved to maintain cellular homeostasis under stressful
conditions including the activation of mitogen-activated
protein kinase (MAPK) pathways. Thus far, 5 MAPK path-
ways have been characterized in S. cerevisiae [1]. The fun-
damental function of these MAPK pathways is to regulate
gene expression in response to various extracellular
signals.
The high osmolarity glycerol (HOG) pathway is one of
the most thoroughly studied MAPK pathways in yeast.* Correspondence: rst@iiserb.ac.in
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unless otherwise stated.The HOG pathway involves the MAPK Hog1 that specif-
ically responds to increased extracellular osmolarity and is
essential for cell survival under these conditions. Yeast
cells respond to osmotic stress by activating Hog1 phos-
phorylation and, subsequently, translocating Hog1 to the
nucleus where it directly interacts with several transcrip-
tion factors to modulate gene expression. Recently, several
studies have demonstrated additional functions of the
HOG MAPK pathway. Evidence shows that the HOG
pathway is essential for regulating the stress adaptation
response induced by heat [2], citric acid [3], or low
temperature [4]. The HOG pathway is also involved in
providing tolerance to methylglyoxal [5] and the bacterial
endotoxin lipopolysaccharide (LPS) [6], and reportedly
plays a role in cell wall maintenance [7] and the distribu-
tion of proteins within the Golgi [8].
Curcumin (diferuloylmethane) is the principal bioactive
agent in the spice turmeric [9]. Turmeric contains a class
of compounds known as the curcuminoids, whichs is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.biomedcentral.com/1471-2180/14/317includes curcumin, desmethoxycurcumin and bisdes-
methoxycurcumin [10]. CUR has been consumed as a
dietary supplement for centuries and has been widely used
in ayurvedic medicines [11]. Because of the promising
therapeutic potential of CUR, several clinical trials have
been initiated or conducted to explore the effect of dietary
CUR in the prevention of neurodegenerative diseases,
several forms of cancer including colon and pancreatic
cancer, bowel diseases, and other diseases [12-15]. Al-
though extensive research has been performed on this
drug, new biological targets of CUR are still being identi-
fied. In previous work, we demonstrated that the medicinal
properties of CUR are largely the result of its cumulative
effect on iron starvation and epigenetic modifications [16].
Thus, the present study was designed to test whether the
Hog1 MAPK is also activated in yeast cells exposed to the
natural compound CUR or not.
We demonstrate that CUR exposure in yeast cells leads
to phosphorylation of Hog1 and up-regulation of GPD1
mRNA levels. The findings presented here strongly indi-
cate that the ability of CUR to induce the osmoresponse
may underlie many of the therapeutic activities of CUR.msb2Δ msb2Δ::KANMX4
11 ssk2Δ/
ssk2Δ




























Reagents and yeast strains
Unless otherwise stated, all the chemicals were purchased
from Sigma-Aldrich. Curcumin (C1386), Bathopenanthro-
linebisulfonic acid- BPS (B1375) and, FeSO4.7H2O (Sigma;
F8263) were purchased from Sigma-Aldrich. To make
synthetic complete (SC) media, amino acids, yeast nitrogen
base (YNB), and ammonium sulfate were mixed together
as per standard protocol [17]. Yeast cells were grown at
28?C in SC media supplemented with 2% dextrose (SCD).
The Saccharomyces cerevisiae strains used in this study are
listed in Table 1.FACS analysis of yeast cells
FACS analysis was performed as described earlier
[18,19]. Briefly, yeast cells in the exponential growth
phase were treated with alpha-factor to synchronize
them in the G1 phase. Cells were released into media
containing DMSO (control) or CUR (50 or 100 μM) at
regular intervals for 6 h. Samples were collected and
harvested by centrifugation. Ethanol was added to the
cell pellets and they were vigorously vortexed. Samples
were then centrifuged and washed once with 50 mM
sodium citrate buffer (pH 7.0). RNase A was added to
the samples and they were incubated at 37?C for 1 h.
RNase A-treated samples containing 20 mg/ml propi-
dium iodide (Sigma) were transferred to a BD FACS flow
cytometer. DNA was detected using a BD FACS Aria III
and analyzed using BD FACS Diva software.Nuclear-cytosolic extracts preparation
The spheroplasts were made from yeast cells as de-
scribed earlier [20]. spheroplasts were washed once with
ice-chilled wash buffer (100 mM KCl, 50 mM HEPES-
KOH pH 7.5, 2.5 mM MgCl2, and 0.4 M Sorbitol) and
lysed in lysis buffer (20mMHEPES at pH7.5, 50mMNaCl,
1mMEDTA, 0.1%Tween 20, 1mM phenylmethylsulpho-
nyl fluoride, protease inhibitor cocktail) with 8 strokes in
a chilled tight-fitting pestle dounce homogenizer, after
15min incubation on ice. Unbroken cells and debris
were removed by centrifugation for 5min at 300g at 4?C.
The cytoplasmic fraction (supernatant) was collected
after a spin at 13000g for 20 min at 4?C and the nuclear-
enriched fraction (pellet) was washed once with lysis
buffer before collection. Normalized volumes of cyto-
plasmic fraction and nuclei fraction were then subjected
to western-blotting analysis.
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Whole cell extracts from untreated and CUR-treated sam-
ples were prepared using the trichloroacetic acid (TCA)
extraction method as described previously [21]. Western
blotting was conducted following protocol used previously
[22,23]. IRDye 700CW anti-rabbit IgG (diluted 1:15 000;
LICOR Biosciences) was used as a secondary antibody.
Blots were scanned using the Odyssey Infrared Imager
(LI-COR Biosciences). The following primary antibodies
were used: anti-GFP (Sigma, G1544), anti-p38/phospho-
Hog1 (Cell Signaling, #92115), and polyclonal antibodies
against recombinant yeast TATA binding protein (TBP)
was raised in rabbit (Bhat Bio-tech India (P) Ltd.).
Isolation of total RNA and real-time PCR
Exponentially growing wild type yeast cells or hog1Δ cells
were treated with CUR (100 μM). Total RNA was isolated
at the indicated time points (0, 30, 60, and 120 min) using
the heat/freeze phenol method described elsewhere [24].
1μg of total RNA was reverse transcribed to synthesize
cDNA using the High Capacity RNA-to-cDNA Kit (Bio-
Rad) according to the manufacturer ? s instructions. Real
time PCR experiments were performed using SYBR Green
Mix (Roche diagnostics, USA) in an ABI real-time PCR
machine. The primers used in this study are listed in
Table 2.
Results
CUR induced growth arrest in yeast cells was rescued by
iron supplementation
To test the dose dependent effect of CUR on yeast cell
cycle progression, we performed FACS analysis. Exponen-
tially growing yeast cells were synchronized in the G1
phase using alpha-factor. After synchronization, G1
arrested cells were released into DMSO (control) or CUR
(50 or 100 μM) supplemented media. The results from the
FACS analysis revealed that the DMSO-treated cells
quickly moved to the G2 phase within 30 minutes of re-
lease from the alpha-factor arrest (Figure 1A), whereas 50
μM CUR treatment led to a delay in the cell cycle progres-
sion (Figure 1B). In the case of 100 μM CUR treatment,
cells remained in the G1 phase throughout the duration of
the experiment (Figure 1C). Even after 360 minutes, cells
released into media containing 100 μM CUR were not
able to progress to the G2 phase (Figure 1C), suggesting
that CUR causes prolonged G1 phase leading to delay inTable 2 List of primers used in the present study
S.no. Gene Forward primer s
1 HOG1 GGATGCCTTGGCTC
2 GPD1 CATTGCCACCGAA
3 ALG9 TGCATTTGCTGTGAcell cycle progression. Previously, we have shown that iron
supplementation rescues the growth inhibitory effect of
CUR on yeast cells [25], hence we also analyzed the cell
cycle progression in presence of curcumin after supple-
mentation with iron. The results revealed that yeast cells
recover from the cell cycle arrest in presence of iron
(Figure 1D). However, the dose of iron used in this experi-
ment (100μM) doesn? t affect cell cycle progression (data
not shown). Altogether, these results indicate that CUR
induced growth arrest in yeast cells can be rescued by iron
supplementation.Hog1 is phosphorylated in response to curcumin
treatment
Previously, we have identified several histone acetyltrans-
ferases (HATs) and histone deacetylases (HDACs) that are
required to provide tolerance to CUR-induced stress [25].
One such HDAC, Rpd3p, is known to be involved in the
transcriptional regulation of osmoresponse genes under
conditions of osmotic stress [26]. Because RPD3 deletion
mutant was hypersensitive to CUR [25], we hypothesized
that CUR might be inducing osmotic stress. To test this
possibility, we analyzed the phosphorylation of Hog1, the
central kinase involved in the regulation of osmoresponse
in yeast. The phosphorylation of Hog1 is a hallmark for the
activation of the osmotic stress response in yeast. To deter-
mine whether the exposure of yeast cells to CUR results in
the activation of Hog1 protein, we analyzed the activation
of Hog1 by performing a western blot with an antibody
specific for the dually phosphorylated form of Hog1 (Thr-
174/Tyr-176). Upon incubation with increasing concentra-
tions of CUR (5? 100 μM) for 1 h, we were able to detect
the phosphorylated form of Hog1 at a dose of 50 or 100
μM CUR through western blot (Figure 2A). To determine
that the observed increase in phosphorylated Hog1 levels
is the result of phosphorylation and not the result of an in-
crease in Hog1, we examined the total levels of Hog1. In
these experiments, we used yeast cells that express GFP-
tagged Hog1 (Hog1-GFP). As illustrated in the western
blot using an anti-GFP antibody, we found no increase in
the band density in response to CUR exposure (Figure 2A).
To further substantiate these results, we measured HOG1
mRNA levels upon exposure to CUR. As shown in
Figure 2B, we failed to observe a significant increase in




Figure 1 CUR treatment induces growth arrest in yeast cells can be rescued upon iron supplementation. Wild type cells (WT-1588-4C)
were cultured in synthetic complete (SC) medium until they reached the exponential phase. Yeast cells were then treated with alpha-factor to
synchronize them in the G1 phase. After synchronization, cells were released into media supplemented with (A) DMSO (control), (B) 50 μM CUR,
(C) 100 μM CUR and (D) 100 μM CUR supplemented with 100 μM Iron. The cultures were sampled at the indicated time points and their DNA
content was then analyzed by FACS.
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ics of CUR-induced Hog1 phosphorylation. As a positive
control, 0.8M NaCl treated samples were analyzed for
Hog1 phosphorylation and as per reports [27-29] phos-
phorylation of Hog1 started very early and remained de-
tectable for 30 min, after which it started to decrease
(Figure 2C). While in case of CUR treatment, it was pos-
sible to detect phosphorylated Hog1 within 15 minutes of
incubation. Interestingly, unlike NaCl, the CUR-induced
phosphorylated Hog1 remained phosphorylated for an ex-
tended duration (at least 120 min) as revealed by western
blotting (Figure 2C). Taken together, these data clearly
suggest that CUR exposure induces Hog1 phosphorylation.
Iron supplementation rescues curcumin-induced Hog1
phosphorylation
Since, we have observed that iron supplementation can
rescue the growth inhibition caused by CUR treatment
(Figure 1). Therefore, we examined whether the supple-
mentation of iron can rescue the CUR-induced Hog1
phosphorylation. First, we analyzed the effect of Iron
(FeSO4) and BPS (Iron chelator) on Hog1 phosphoryl-
ation. As shown in Figure 3A and B, iron or BPS doesn? t
causes phosphorylation of Hog1, as no signal appeared inwestern blotting with phospho-Hog1 antibody. Next, we
treated yeast cells with 100 μM CUR to observe the Hog1
phosphorylation till 4 h. We quantified the Hog1 phos-
phorylation levels using image J software and results
revealed that phosphorylation remains almost constant till
4 h (Figure 3C, lower panel, bar diagram). Next, we
treated exponentially growing yeast cells with 100 μM
CUR for 30 min followed by supplementation of iron (100
μM) in the media. Cells were harvested till 4h post-
treatment with iron. Our western blotting revealed that
the levels of phosphorylated Hog1 was reduced signifi-
cantly after addition of iron (Figure 3D, lower panel, bar
diagram). These results clearly suggest that CUR-induced
iron starvation leads to Hog1 phosphorylation and that
can be rescued upon iron supplementation.
Since, we have observed the phosphorylation of Hog1
in response to CUR exposure; next we were motivated
to observe the effect of CUR on HOG1 deletion mutant.
We arrested hog1Δ cells with alpha-factor to arrest them
in G1 phase as described in materials and methods. G1
arrested hog1Δ cells were released in fresh media con-
taining DMSO or media supplemented with 100 μM
CUR. The results from the FACS analysis revealed that
the DMSO-treated cells quickly moved to the G2 phase
Figure 2 Hog1 protein is phosphorylated in response to curcumin treatment. (A) A yeast strain expressing GFP-tagged Hog1 (Hog1-GFP)
was grown until the exponential phase. Protein was extracted from cells incubated for 1 h with increasing concentrations of CUR (0, 5, 10, 20, 50,
and 100 μM). The phosphorylated form of Hog1 was detected using an anti-phospho-p38 antibody (phospho-Hog1). The western blot membranes
were probed for total Hog1 using a polyclonal anti-GFP antibody and this served as a loading control. (B) An exponentially growing wild type yeast
strain was exposed to 100 μM CUR for 2 h. Samples were taken after 0, 30, 60, and 120 min of incubation. The expression of HOG1 mRNA levels was
examined by SYBR Green real-time PCR. The error bars represent the standard deviation (SD) of three independent replicates. (C) Protein was extracted
from cells incubated with either 0.8 M NaCl or 100 μM CUR at the indicated time points. The western blot membranes were probed for phospho-Hog1
or total Hog1 (anti-GFP). The anti-GFP signal served as a loading control.
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(Figure 3Ea), whereas 100 μM CUR treatment led to a
delay in cell cycle progression (Figure 3Eb). While, the cell
cycle progression was resumed in presence of curcumin
after supplementation with iron (Figure 3Ec). The results
revealed that hog1Δ yeast mutant can also recover cell
cycle arrest in presence of iron. The dose of iron used in
this experiment (100μM) doesn? t affect cell cycle progres-
sion (Figure 3Ed). Altogether, these results indicate that
CUR induced growth arrest in yeast cells can be rescued
by iron supplementation.SSK2, MSB2, and PTC2 deletions abrogate curcumin-induced
Hog1 phosphorylation
As a member of MAPK family, Hog1 is phosphorylated by
several upstream kinases that are involved in mediating
osmostress response. We evaluated the phosphorylation
of Hog1 protein in several HOG pathway mutants to
investigate the role of these factors in mediating CUR-
induced Hog1 phosphorylation. Wild type and mutant
yeast strains were grown until they reached the exponen-
tial phase before being treated with 100 μM CUR for 1 h.
Whole cell extracts were prepared as detailed in the Mate-
rials and Methods and a western blot was performed to
analyze the phosphorylation of Hog1. As a control, cells
were treated with the same concentration of DMSO. The
western blot revealed that the phosphorylation of Hog1
was reduced in the ssk2Δ, msb2Δ, ptc2Δ and pbs2Δdeletion mutants relative to that in wild type cells
(Figure 4A and B). These results suggest that Ssk2p,
msb2p, Ptc2p, and Pbs2p are important components of
the HOG pathway and are required for the optimal activa-
tion of Hog1 in response to CUR-induced stress.CUR-induced phosphorylated Hog1 gets translocated to the
nucleus leading to over-expression of GPD1 mRNA levels
In response to osmotic stress, Hog1 is phosphorylated and
translocated into nucleus where it regulates the expression
of several osmoresponsive genes [30,31]. Hence, we were
interested to determine the localization of CUR-induced
phosphorylated Hog1. We treated exponentially growing
yeast cells with 100 μM CUR for 1 h. We fractionated
whole cell extract of yeast into nuclear and cytosolic
fractions following a protocol as described in materials
and methods. Our western blotting with phospho-hog1
antibody revealed that phosphorylated hog1 protein is
localized into the nuclear fraction (Figure 5A). This result
suggests that CUR-induced phosphorylated Hog1 is
translocated to nucleus. It is well established that Hog1 is
phosphorylated and translocated to nucleus in response to
osmotic stress. Once it is in the nucleus, Hog1 regulates
the expression of various osmoresponse genes [30,31].
This prompted us to analyze the expression of one such
gene, GPD1 that encodes a factor involved in glycerol bio-
synthesis during osmotic stress [32]. Wild type or hog1Δ
yeast cells were treated with CUR (100 μM) and harvested
Figure 3 (See legend on next page.)
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Figure 3 Analysis of Hog1 phosphorylation after addition of iron. (A) A yeast strain expressing GFP-tagged Hog1 (Hog1-GFP) was grown
until the exponential phase. Protein was extracted from cells incubated for 1 h with increasing concentrations of iron (50, 100 and 200 μM/1h).
The phosphorylated form of Hog1 was detected using an anti-phospho-p38 antibody (phospho-Hog1). The western blot membranes were
probed for total Hog1 using a polyclonal anti-GFP antibody and this served as a loading control (B) Cells were treated with BPS for 30 min
followed by addition of iron (100 μM) and cells were harvested at indicated time points. Proteins were extracted and phosphorylation of hog1
was detected by phospho-hog1 antibody. The western blot membranes were probed for total Hog1 using a polyclonal anti-GFP antibody and
this served as a loading control (C) Protein was extracted from cells incubated with 100 μM CUR at the indicated time points. The western blot
membranes were probed for phospho-Hog1 and anti-GFP (Total Hog1p). The intensity of phosphorylated Hog1 was quantified using Image J
software and normalized with respect to total Hog1p levels (anti-GFP) and shown in the form of bar diagramme. The error bars represent the
standard deviation (SD) of three independent replicates. (D) Yeast strain expressing GFP-tagged Hog1 (Hog1-GFP) was treated with 100 μM CUR
for 30 min followed by addition of iron (100 μM). Cells were harvested at indicated time points in figure and protein were extracted. The
phosphorylation of hog1 was detected by phospho-hog1 antibody. The western blot membranes were probed for total Hog1 using a polyclonal
anti-GFP antibody and this served as a loading control. The intensity of phosphorylated Hog1 was quantified using Image J software and normalized
with respect to total Hog1p levels (anti-GFP) and shown in the form of bar diagramme. The error bars represent the standard deviation (SD) of three
independent replicates. (E) Hog1Δ cells were treated with alpha-factor to synchronize them in the G1 phase. After synchronization, cells were released
into media supplemented with (a) DMSO (control), (b) 100 μM CUR, (c) 100 μM CUR supplemented with 100 μM Iron and (D) 100 μM Iron. The
cultures were sampled at the indicated time points and their DNA content was then analyzed by FACS.
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ment. Total RNA was extracted, reverse-transcribed to
cDNA, and the expression of GPD1 was analyzed using
real-time PCR. Transcript levels were normalized to the
reference gene ALG9. In case of wild type cells we ob-
served a consistent 2? 3 fold increase in the expression of
GPD1 within 30 min of CUR exposure (Figure 5B). This
increase was maintained for 2 h (Figure 5B). This stronglyFigure 4 Analysis of Hog1 phosphorylation in response to CUR treatm
pathway mutant yeast strains were grown in SC media until they reached
and protein was extracted as described in the Materials and Methods. The
control, the same blots were reprobed with anti-TBP antibody. Equal prote
blot membrane.indicates that upon CUR exposure, Hog1 is not only phos-
phorylated, but also causes an up-regulation of GPD1
mRNA levels. To ensure that the up-regulation of GPD1
upon CUR treatment is due to Hog1, we analysed the ex-
pression of GPD1 mRNA in hog1Δ cells. Our quantitative
PCR revealed that hog1Δ cells failed to up-regulate GPD1
mRNA upon CUR treatment (Figure 5B) suggesting the
specific requirement of Hog1. Altogether, these resultsent in HOG pathway mutants. (A and B) Wild type and HOG
the exponential phase. Cells were treated with 100 μM CUR for 1 h
western blot membranes were probed for phospho-Hog1. As a loading
in loading was further confirmed by Ponceau S staining of the western
Figure 5 CUR-induces Hog1 phosphorylation dependent over-expression GPD1 mRNA. (A) Nuclear-cytoplasmic extracts were made as described
in materials and methods. Whole cell extract (WCE), cytoplasmic fraction (CYT) and nuclear fraction (NUC) were loaded on SDS-PAGE and transferred
onto nitrocellulose membrane. Western blot with anti-H3K36me3 antibody was performed to ensure the integrity of extract fractionation (H3K36me3 is a
nuclear protein). The distribution of phosphorylated Hog1 was analyzed by probing with phospho-hog1 antibody. (B) An exponentially growing wild type
or hog1Δ yeast strain was exposed to 100 μM CUR for 2 h. Samples were taken after 0, 30, 60, and 120 min of incubation. The expression of GPD1 mRNA
levels in wild type or hog1Δ cells was examined by SYBR Green real-time PCR. The fold-change in GPD1 mRNA levels was normalized to the
reference gene ALG9. The error bars represent the standard deviation (SD) of three independent replicates.
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quires Hog1 and mediated through Hog1 phosphorylation
in yeast cells.
Discussion
The diverse pharmacological activities of CUR have been
attributed to its actions on multiple cellular targets, either
by interacting physically with the targets themselves or by
modulating transcription factors, enzyme activity, or gene
expression. In this study, we examined the requirement
for a functional HOG pathway to cope with CUR-induced
stress. If signaling through Hog1 is essential for its func-
tion under CUR-induced stress, Hog1 should be activated
by phosphorylation of residues Thr174 and Tyr176, which
is required for Hog1 activation. Using commercial anti-
bodies raised against phosphorylated human p38, we were
able to detect the phosphorylation of Hog1 protein after
exposure of CUR (Figure 2A).
Yeast Hog1 is a stress-activated kinase that is thought to
be activated exclusively by osmotic stress. However, recent
studies have implicated the role of this MAPK in mediat-
ing tolerance to a variety of stress conditions including os-
motic [33], oxidative [34], heat [2], arsenic [35], and citricacid stress [3]. We have observed the phosphorylation of
Hog1 in the presence of CUR (Figure 2A) and provided
evidence for the activation of the HOG pathway in yeast.
Hog1 activation has been most extensively characterized
under conditions of hyperosmotic shock. The exposure of
S. cerevisiae to high-osmolarity leads to a rapid (<30 min)
and sustained (up to several hours depending on the se-
verity of the conditions) phosphorylation of Hog1 protein
[27-29]. To determine whether CUR induces a slow or a
rapid response, phosphorylation of Hog1 was measured at
intervals following the addition of 100 μM CUR. Addition
of CUR induced a rapid increase in Hog1 phosphoryl-
ation, but unlike NaCl-induced Hog1 phosphorylation, it
sustained for an extended period of time (Figure 2C). It
has been well documented that curcumin antagonizes
yeast growth by chelating iron [36]. Previously, we have
demonstrated that supplementation of iron rescued the
cells from the growth arrest phenotype [20]. Moreover, we
also found a novel way to reset epigenetic marks back to
their normal levels by iron supplementation in the pres-
ence of curcumin [20]. Hence, we were curious to under-
stand whether CUR-induced phosphorylation of Hog1 can
be restored after iron supplementation. Interestingly, the
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presence of iron (Figure 3D) suggesting that the activation
of MAPK Hog1 by CUR is also dependent on its iron che-
lating property.
Hog1 is activated through a series of phosphorylation
events involving the MAPK kinase Pbs2 and several
other upstream factors [33,37]. To test the role of up-
stream components of the HOG pathway in the cellular
response to CUR, we monitored the phosphorylation of
Hog1 in yeast strains carrying mutations in components
of the HOG pathway. As shown in Figure 4A and B, the
pbs2Δ mutant was defective in Hog1 phosphorylation
because it is the only immediate upstream kinase for
Hog1. To test the role of upstream members of the HOG
pathway in the cellular response to CUR, we monitored
the phosphorylation of Hog1 in yeast strains carrying mu-
tations in the components of the HOG pathway. Interest-
ingly, we also observed Hog1 phosphorylation defects in
SSK2, MSB2, and PTC2 deletion mutants, suggesting the
requirement of these factors for optimal Hog1 phosphor-
ylation in response to CUR treatment. The comprehensive
CUR-induced growth inhibition analysis in the mutants
incapable of phosphorylating Hog1 warrants future study,Figure 6 Proposed model showing molecular mode of action of CUR
osmotic stress. We have shown that CUR-induced phosphorylated Hog1 mwhere methods outlined by the Clinical Laboratory
Standards Institute (CLSI) M38-A [38] or the European
Committee on Antimicrobial Susceptibility Testing
(EUCAST) [39] can be used.
One of the main functions of the MAPK pathway is
the regulation of transcriptional events in response to
specific stimuli. Because of its phosphorylation, Hog1
gets translocated to the nucleus [30], where it targets
various transcription factors, leading to upregulation of
GPD1 mRNA levels [40]. Our results also revealed that
CUR-induced phosphorylated Hog1 migrates to nucleus
(Figure 5A). We have also demonstrated that CUR ex-
posure causes up-regulation of GPD1 (Figure 5B), which
is required for the synthesis of a major osmolyte, gly-
cerol. Elevated glycerol production is a prerequisite for
the adaptation of S. cerevisiae to hyperosmotic stress
[40]. Interestingly, the expression of GPD1 in response
to CUR treatment requires functional Hog1 protein
(Figure 5B). Notably, to the best of our knowledge, for
the first time, we report that the CUR exposure leads to
Hog1 phosphorylation in S. cerevisiae and this is
followed by the activation of GPD1 gene expression. The
CUR has several molecular targets, other than Hog1. ForonS. cerevisiae. After entering into yeast cells CUR causes activation of
igrates to nucleus leading to up-regulation of GPD1 mRNA levels.
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pathways such as JAK/STAT, Wnt/β-catanin, Notch,
PI3K/PKB, AMPK, DNA damage checkpoint pathway
[25,41-45] and many others. Here, we have identified
Hog1 as an additional target of CUR. Considering Hog1
is central kinase in osmotic stress pathway, the activa-
tion of Hog1 upon CUR treatment indicates that CUR
induces osmotic stress.
Conclusions
Recently, the identification of bioactive dietary compo-
nents has received particular interest in the field of
pharmacology. Curcumin has gained immense attention
for its varied therapeutic and prophylactic applications.
Our results reveal new aspects of the response of S. cerevi-
siae to CUR-induced stress (Figure 6). We have identified
additional functions of the Hog1 MAPK in providing tran-
scriptional activity upon exposure to CUR. We believe
that the findings presented in this work will enhance the
understanding on the mode of curcumin action.
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